Literature DB >> 17622492

Emergency department arrival times after acute ischemic stroke during the 1990s.

Dawn O Kleindorfer1, Joseph P Broderick, Jane Khoury, Matthew L Flaherty, Daniel Woo, Kathleen Alwell, Charles J Moomaw, Arthur Pancioli, Edward Jauch, Rosie Miller, Brett M Kissela.   

Abstract

INTRODUCTION: Only 8% of ischemic stroke (IS) patients are eligible for rt-PA, and the largest exclusion criterion is delayed time of presentation to the ED. We sought to investigate whether patients are arriving to the ED more quickly in 1999 than in 1993/94 within our large biracial population of 1.3 million.
METHODS: Using ICD-9 codes 430-436, we ascertained all stroke events that presented to a local ED within our population in 7/93-6/94 and again in 1999. Times were recorded as documented in the medical record.
RESULTS: There were 1,792 IS patients that presented to an ED in 1993/94 and 1,973 in 1999. The percentage of patients with documented times arriving in under 3 h improved slightly in 1999 (26% vs. 23% in 93/94, P = 0.03), however, the percentage arriving in under 2 h did not. Blacks significantly improved in arrivals under 3 h: 26% in 1999 compared to 17% in 1993/94 (P = 0.01), while whites did not (26% vs. 25%, P = 0.29). In 1999, only 9% of patients arrived from 3-8 h after symptom onset, the large majority of times were either estimated, unknown, or >8 h. DISCUSSION: We found only marginal improvement in arrival times during the 1990s. In our population, blacks improved in early arrival after symptom onset, while whites did not. Very few patients arrive 3-8 h after onset; therefore expansion of the acute treatment time window to 8 h is unlikely to dramatically affect acute treatment of ischemic stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17622492     DOI: 10.1007/s12028-007-0029-5

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  13 in total

1.  Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

Authors:  I L Katzan; A J Furlan; L E Lloyd; J I Frank; D L Harper; J A Hinchey; J P Hammel; A Qu; C A Sila
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

2.  Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989.

Authors:  R D Brown; G W Petty; W M O'Fallon; D O Wiebers; J P Whisnant
Journal:  Stroke       Date:  1998-10       Impact factor: 7.914

3.  Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

Authors: 
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

4.  Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

Authors: 
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

5.  Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.

Authors:  S D Reed; S C Cramer; D K Blough; K Meyer; J G Jarvik
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

6.  Extending tissue plasminogen activator use to community and rural stroke patients.

Authors:  José G Merino; Brian Silver; Edward Wong; Blaine Foell; Bart Demaerschalk; Arturo Tamayo; Fali Poncha; Vladimir Hachinski
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

7.  Improving delivery of acute stroke therapy: The TLL Temple Foundation Stroke Project.

Authors:  Lewis B Morgenstern; Lara Staub; Wenyaw Chan; Theodore H Wein; L Kay Bartholomew; Mary King; Robert A Felberg; W Scott Burgin; Janet Groff; Susan L Hickenbottom; Kamaldeen Saldin; Andrew M Demchuk; Anjali Kalra; Anupma Dhingra; James C Grotta
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

8.  Stroke in a biracial population: the excess burden of stroke among blacks.

Authors:  Brett Kissela; Alexander Schneider; Dawn Kleindorfer; Jane Khoury; Rosemary Miller; Kathleen Alwell; Daniel Woo; Jerzy Szaflarski; James Gebel; Charles Moomaw; Arthur Pancioli; Edward Jauch; Rakesh Shukla; Joseph Broderick
Journal:  Stroke       Date:  2004-02       Impact factor: 7.914

9.  The effect of race and gender on patterns of rt-PA use within a population.

Authors:  Dawn Kleindorfer; Alexander Schneider; Brett M Kissela; Daniel Woo; Jane Khoury; Kathleen Alwell; Rosemary Miller; James Gebel; Jerzy Szaflarski; Arthur Pancioli; Edward Jauch; Charles Moomaw; Rakesh Shukla; Joseph P Broderick
Journal:  J Stroke Cerebrovasc Dis       Date:  2003 Sep-Oct       Impact factor: 2.136

10.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.

Authors:  R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more
  16 in total

1.  Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.

Authors:  D C Morris; M Chopp; L Zhang; M Lu; Z G Zhang
Journal:  Neuroscience       Date:  2010-08-25       Impact factor: 3.590

2.  Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.

Authors:  Felipe de Los Ríos la Rosa; Jane Khoury; Brett M Kissela; Matthew L Flaherty; Kathleen Alwell; Charles J Moomaw; Pooja Khatri; Opeolu Adeoye; Daniel Woo; Simona Ferioli; Dawn O Kleindorfer
Journal:  Stroke       Date:  2012-03-22       Impact factor: 7.914

3.  Delay in presentation after acute ischemic stroke: the Careggi Hospital Stroke Registry.

Authors:  Innocenti Eleonora; Nencini Patrizia; Romani Ilaria; Del Bene Alessandra; Arba Francesco; Piccardi Benedetta; Pracucci Giovanni
Journal:  Neurol Sci       Date:  2013-06-27       Impact factor: 3.307

4.  Social factors influencing hospital arrival time in acute ischemic stroke patients.

Authors:  Christina Iosif; Mathilda Papathanasiou; Eleftherios Staboulis; Athanasios Gouliamos
Journal:  Neuroradiology       Date:  2011-05-12       Impact factor: 2.804

5.  Planning a campaign to fight stroke: an educational pilot project in La Spezia, Italy.

Authors:  Elisa Giorli; E Schirinzi; R Baldi; A Mannironi; E Raggio; N Reale; C Gandolfo; M Del Sette
Journal:  Neurol Sci       Date:  2019-06-10       Impact factor: 3.307

6.  Which stroke symptoms prompt a 911 call? A population-based study.

Authors:  Dawn Kleindorfer; Christopher J Lindsell; Charles J Moomaw; Kathleen Alwell; Daniel Woo; Matthew L Flaherty; Opeolu Adeoye; Tarek Zakaria; Joseph P Broderick; Brett M Kissela
Journal:  Am J Emerg Med       Date:  2010-01-28       Impact factor: 2.469

7.  Impact of a multimedia campaign to increase intention to call 9-1-1 for stroke symptoms, upstate New York, 2006-2007.

Authors:  Janine M Jurkowski; Dayna M Maniccia; Deborah A Spicer; Barbara A Dennison
Journal:  Prev Chronic Dis       Date:  2010-02-15       Impact factor: 2.830

Review 8.  Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.

Authors:  Johan Herlitz; Birgitta Wireklintsundström; Angela Bång; Annika Berglund; Leif Svensson; Christian Blomstrand
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-09-06       Impact factor: 2.953

Review 9.  Temporal trends in acute stroke management.

Authors:  Dawn Kleindorfer; Felipe de los Rios La Rosa; Pooja Khatri; Brett Kissela; Jason Mackey; Opeolu Adeoye
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

10.  Reasons for low thrombolysis rate in a Norwegian ischemic stroke population.

Authors:  Kashif Waqar Faiz; Antje Sundseth; Bente Thommessen; Ole Morten Rønning
Journal:  Neurol Sci       Date:  2014-07-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.